Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 31% ± 14% | |
peripheral blood | 13 studies | 26% ± 6% | |
brain | 9 studies | 28% ± 13% | |
intestine | 8 studies | 30% ± 14% | |
kidney | 7 studies | 26% ± 5% | |
eye | 7 studies | 27% ± 13% | |
lymph node | 5 studies | 28% ± 11% | |
placenta | 4 studies | 33% ± 12% | |
bone marrow | 4 studies | 21% ± 3% | |
uterus | 4 studies | 31% ± 15% | |
breast | 4 studies | 27% ± 5% | |
pancreas | 3 studies | 46% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 12627.89 | 258 / 258 | 100% | 245.48 | 230 / 230 |
esophagus | 100% | 10648.74 | 1445 / 1445 | 100% | 188.71 | 183 / 183 |
intestine | 100% | 10147.29 | 966 / 966 | 100% | 211.13 | 527 / 527 |
liver | 100% | 10698.97 | 226 / 226 | 100% | 182.84 | 406 / 406 |
ovary | 100% | 8287.51 | 180 / 180 | 100% | 311.34 | 430 / 430 |
pancreas | 100% | 4285.17 | 328 / 328 | 100% | 175.57 | 178 / 178 |
skin | 100% | 10316.16 | 1809 / 1809 | 100% | 223.34 | 472 / 472 |
thymus | 100% | 9127.46 | 653 / 653 | 100% | 225.98 | 605 / 605 |
uterus | 100% | 10632.76 | 170 / 170 | 100% | 256.03 | 459 / 459 |
brain | 100% | 14814.15 | 2641 / 2642 | 100% | 323.26 | 705 / 705 |
prostate | 100% | 10913.43 | 245 / 245 | 100% | 275.08 | 500 / 502 |
kidney | 100% | 9937.79 | 89 / 89 | 99% | 178.06 | 895 / 901 |
stomach | 100% | 7669.67 | 359 / 359 | 99% | 193.31 | 284 / 286 |
breast | 100% | 8341.35 | 459 / 459 | 99% | 239.96 | 1107 / 1118 |
bladder | 100% | 9752.86 | 21 / 21 | 99% | 239.37 | 499 / 504 |
lung | 100% | 8186.89 | 576 / 578 | 98% | 230.74 | 1135 / 1155 |
adipose | 100% | 8207.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9620.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 173.63 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 149.39 | 29 / 29 |
muscle | 100% | 7407.70 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7340.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 227.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 143.09 | 1 / 1 |
peripheral blood | 99% | 8961.49 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 7087.09 | 846 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | MLF2 |
Protein name | Myeloid leukemia factor 2 Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2) MLF2 protein (Myeloid leukemia factor 2) (cDNA, FLJ94652, Homo sapiens myeloid leukemia factor 2 (MLF2), mRNA) |
Synonyms | hCG_25928 |
Description | |
Accessions | ENST00000539187.5 ENST00000540710.5 Q15773 F5H800 F5H7L5 ENST00000435120.5 Q5U0N1 ENST00000203630.10 ENST00000537126.5 ENST00000536207.1 F5H0Y3 |